Invention Grant
- Patent Title: Pyridazine derivatives
- Patent Title (中): 哒嗪衍生物
-
Application No.: US10516876Application Date: 2003-05-12
-
Publication No.: US07129241B2Publication Date: 2006-10-31
- Inventor: Hans-Michael Eggenweiler , Michael Wolf
- Applicant: Hans-Michael Eggenweiler , Michael Wolf
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent Gesellschaft
- Current Assignee: Merck Patent Gesellschaft
- Current Assignee Address: DE Darmstadt
- Agency: Millen, White, Zelano & Branigan, P.C.
- Priority: DE10224888 20020605
- International Application: PCT/EP03/04930 WO 20030512
- International Announcement: WO03/104204 WO 20031218
- Main IPC: C07D403/12
- IPC: C07D403/12 ; C07D237/04 ; A61K31/501 ; A61K31/50 ; A61P11/06
Abstract:
Pyridazine derivatives of the formula (I) act as phosphodiesterase IV inhibitors and can be employed for the treatment of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS
Public/Granted literature
- US20050176714A1 Pyridazine derivatives Public/Granted day:2005-08-11
Information query
